# University of Oklahoma

Canonical: https://abierto.us/vendors/university-of-oklahoma-gy8nmuzqxvs7

- UEI: GY8NMUZQXVS7
- CAGE: 4B862
- Location: Oklahoma City, OK
- Awards in window: 28 (44 transactions), $4,410,664 obligated, January 9, 2026 to September 10, 2026

## Awarding agencies

- National Institutes of Health: 15 awards, $4,076,323
- Department of Veterans Affairs: 5 awards, $182,333
- Department of the Navy: 5 awards, $144,221
- Indian Health Service: 1 awards, $13,817
- U.S. Census Bureau: 1 awards, $0
- Offices, Boards and Divisions: 1 awards, -$6,029

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $2,967,824
- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $1,128,250
- 611310 Colleges, Universities, and Professional Schools: $223,472
- 325412 Pharmaceutical Preparation Manufacturing: $83,330
- 611430 Professional and Management Development Training: $13,817
- 541720 Research and Development in the Social Sciences and Humanities: $0
- 621111 Offices of Physicians (except Mental Health Specialists): -$6,029

## Competition

- Full and Open Competition: 15 awards
- Not Competed: 6 awards
- Competed Under SAP: 5 awards
- Not Competed Under SAP: 1 awards
- Not Available for Competition: 1 awards

## Largest awards

- 75N92019F00074 (delivery order): $1,667,563, National Institutes of Health Nhlbi. Strong Heart Study (Shs) - Coordinating Center (Cc) - Task Order 001. https://www.usaspending.gov/award/CONT_AWD_75N92019F00074_7529_75N92019D00027_7529/
- 75N91026F00001 (delivery order): $1,147,754, NIH NCI. Triple Negative Breast Cancer Vaccines. https://www.usaspending.gov/award/CONT_AWD_75N91026F00001_7529_75N91024D00005_7529/
- 75N92019F00074 (delivery order): $811,462, National Institutes of Health Nhlbi. Strong Heart Study (Shs) - Field Center (Fc) - Task Order 001. https://www.usaspending.gov/award/CONT_AWD_75N92019F00074_7529_75N92019D00028_7529/
- 75N92026F00001 (delivery order): $469,049, National Institutes of Health Nhlbi. Strong Heart Study (Shs) - University of Oklahoma, Field Center (Fc), Task Area C: Data Book. https://www.usaspending.gov/award/CONT_AWD_75N92026F00001_7529_75N92019D00028_7529/
- 36C25926P0013 (purchase order): $86,034, Network Contract Office 19. Radiopharmaceuticals for Mus Dash 8 Extension. https://www.usaspending.gov/award/CONT_AWD_36C25926P0013_3600_-NONE-_-NONE-/
- 36C25922C0002 (definitive contract): $79,252, Network Contract Office 19. Interventional Radiology Services. https://www.usaspending.gov/award/CONT_AWD_36C25922C0002_3600_-NONE-_-NONE-/
- N0622A26FA281 (delivery order): $70,602, Navy Medicine Professional. University of Oklahoma Health Sciences Center SPR 1301336995. https://www.usaspending.gov/award/CONT_AWD_N0622A26FA281_9700_N0018925GZ079_9700/
- N0622A26FA106 (delivery order): $39,052, Navy Medicine Professional. Ok, University of Oklahoma Health Sciences Center SPR 1301319610. https://www.usaspending.gov/award/CONT_AWD_N0622A26FA106_9700_N0018925GZ079_9700/
- N0622A26FA058 (delivery order): $19,987, Navy Medicine Professional. Tuition and Fees Ok, University of Oklahoma Health Sciences Center. https://www.usaspending.gov/award/CONT_AWD_N0622A26FA058_9700_N0018925GZ079_9700/
- 36C24E25C0002 (definitive contract): $19,751, Rpo East. Sequencing Services (Research - Academic Affiliate). https://www.usaspending.gov/award/CONT_AWD_36C24E25C0002_3600_-NONE-_-NONE-/
- 75H71126P00114 (purchase order): $13,817, Indian Health Service. To Provide Accredited Continuous Education Dental Training Services and Venue. https://www.usaspending.gov/award/CONT_AWD_75H71126P00114_7527_-NONE-_-NONE-/
- N0622A25FA370 (delivery order): $13,462, Navy Medicine Professional. Tuition and Fees. https://www.usaspending.gov/award/CONT_AWD_N0622A25FA370_9700_N0018925GZ079_9700/
- N0622A25FA295 (delivery order): $1,117, Navy Medicine Professional. Ok, University of Oklahoma Health Sciences Center Tuition and Fees for Fall Term Aug - Dec 2025. https://www.usaspending.gov/award/CONT_AWD_N0622A25FA295_9700_N0018925GZ079_9700/
- 1333LB24P00000032 (purchase order): $0, Department of Commerce Census. Asa Research Fellowship. https://www.usaspending.gov/award/CONT_AWD_1333LB24P00000032_1323_-NONE-_-NONE-/
- 75N91020F00005 (delivery order): $0, NIH NCI. Evaluation of Two Different Classes of Compounds (Stat3 Inhibitors and Serms) for the Prevention of Urinary Bladder Cancer.. https://www.usaspending.gov/award/CONT_AWD_75N91020F00005_7529_75N91019D00020_7529/
- 75N91022F00002 (delivery order): $0, NIH NCI. Title: Bladder Cancer Chemoprevention Using the Androgen Receptor Inhibitor Apalutamide. https://www.usaspending.gov/award/CONT_AWD_75N91022F00002_7529_75N91019D00020_7529/
- 75N91022F00003 (delivery order): $0, NIH NCI. Task Order Title: Preventing Lung Adenocarcinoma (Luad) Using Trail Inducing Agent, ONC201. https://www.usaspending.gov/award/CONT_AWD_75N91022F00003_7529_75N91019D00020_7529/
- 75N91023F00001 (delivery order): $0, NIH NCI. Task Order Title: Colorectal Cancer (Crc) Prevention by Tpst-1495 in Pirc Rat Model. https://www.usaspending.gov/award/CONT_AWD_75N91023F00001_7529_75N91019D00020_7529/
- 75N91025F00001 (delivery order): $0, NIH NCI. Task Order Title: Further Development of Mitochondria-Targeted Honokiol for Prevention of Lung Cancer: Adenocarcinoma and Squamous Cell Carcinoma. https://www.usaspending.gov/award/CONT_AWD_75N91025F00001_7529_75N91024D00005_7529/
- 75N92024F00001 (delivery order): $0, National Institutes of Health Nhlbi. Strong Heart Study (Shs)- University of Oklahoma-Field Center (Fc), Task Area B.3, Year 3. https://www.usaspending.gov/award/CONT_AWD_75N92024F00001_7529_75N92019D00028_7529/
- 36C25923D0003: $0, Network Contract Office 19. Radiopharmaceuticals Eo 14398. https://www.usaspending.gov/award/CONT_IDV_36C25923D0003_3600/
- 75N91019D00020: $0, NIH NCI. Eo 14398; Preclinical Prevent Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers. https://www.usaspending.gov/award/CONT_IDV_75N91019D00020_7529/
- 75N91024D00005: $0, NIH NCI. Preclinical Efficacy & Intermediate Endpoint Biomarkers IDIQ Contract in Support of the Prevent Cancer Preclinical Drug Development Program. https://www.usaspending.gov/award/CONT_IDV_75N91024D00005_7529/
- 36C25924P0004 (purchase order): -$2,704, Network Contract Office 19. Pet/Ct Radiopharmaceuticals. https://www.usaspending.gov/award/CONT_AWD_36C25924P0004_3600_-NONE-_-NONE-/
- 75N91024F00002 (delivery order): -$4,328, NIH NCI. To Title: a Novel Mrna Vaccine to Prevent Triple Negative Breast Cancer IDIQ Title: Prevent Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers. https://www.usaspending.gov/award/CONT_AWD_75N91024F00002_7529_75N91024D00005_7529/
- 75N91021F00003 (delivery order): -$5,985, NIH NCI. Prevent Cancer Preclinical Drug Development Program, Task Order Title: a Novel Multi-Antigen Vaccine (Tnbcvax) to Prevent Triple Negative Breast Cancer. https://www.usaspending.gov/award/CONT_AWD_75N91021F00003_7529_75N91019D00020_7529/
- 15JA6225P00000019 (purchase order): -$6,029, U.S. Attorneys Office-Ok(N). Expert Witness Child Abuse Ou Department of Pediatrics Dr. Michael Baxter U.S. Vs. Daniel Ash (25-CR-00088) Ausa Alicia Hockenbury Period of Performance: 05/12/2025-05/11/2026. https://www.usaspending.gov/award/CONT_AWD_15JA6225P00000019_1501_-NONE-_-NONE-/
- 75N91021F00002 (delivery order): -$9,191, NIH NCI. Project Title: Further Evaluation of Amhr2-Ed Antigens for Epithelial Ovarian Carcinoma. https://www.usaspending.gov/award/CONT_AWD_75N91021F00002_7529_75N91019D00020_7529/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/university-of-oklahoma-gy8nmuzqxvs7.